Rogelio Manuel
Leira Muiño
Publicaciones (176) Publicaciones de Rogelio Manuel Leira Muiño
2024
-
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
Frontiers in Neurology , Vol. 15
2023
-
Association between periodontitis and peripheral markers of innate immunity activation and inflammation
Journal of Periodontology, Vol. 94, Núm. 1, pp. 11-19
-
Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population
Therapeutic Advances in Chronic Disease, Vol. 14
2022
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
-
Interictal amylin levels in chronic migraine patients: A case-control study
Cephalalgia, Vol. 41, Núm. 5, pp. 604-612
-
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
Journal of Headache and Pain, Vol. 22, Núm. 1
-
Mild systemic inflammation enhances response to OnabotulinumtoxinA in chronic migraineurs
Scientific Reports, Vol. 11, Núm. 1
-
The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish
Headache, Vol. 61, Núm. 9, pp. 1403-1410
2020
-
Author response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine
Neurology
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
-
Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine
Toxins, Vol. 12, Núm. 8
-
Pentraxin 3 (PTX3): A molecular marker of endothelial dysfunction in chronic migraine
Journal of Clinical Medicine, Vol. 9, Núm. 3
-
Prolonged Migraine Stuttering Aura: Structural, Functional, and Video Neuroimaging Study of an Atypical Migraine Aura. A Case Report
Headache, Vol. 60, Núm. 4, pp. 776-780
-
Severe periodontitis is linked with increased peripheral levels of sTWEAK and PTX3 in chronic migraineurs
Clinical Oral Investigations, Vol. 24, Núm. 2, pp. 597-606
2019
-
Association between periodontitis and chronic migraine: a case–control study
Odontology, Vol. 107, Núm. 1, pp. 90-95
-
Cefalea en racimos y cefaleas secundarias
Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 71, pp. 4163-4174
-
Cluster headache and secondary headaches
Medicine (Spain), Vol. 12, Núm. 71, pp. 4163-4174
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417